Hellman & Friedman Acquires Cordis from Cardinal Health

Cordis Acquires MedAlliance

October 17, 2022

Medical Devices

Cordis, the interventional cardiovascular device company, announced the acquisition of Switzerland-based MedAlliance, developer of the SELUTION SLR sirolimus drug‑eluting balloon. The deal includes an initial $35M investment, $200M payable at closing (expected 2023), plus up to $125M in regulatory milestones and up to $775M in commercial milestones through 2029; Cordis will begin co-promotion of SELUTION SLR in markets where it is available.

Haemonetics Acquires Cardiva Medical

January 20, 2021

Medical Devices

Haemonetics Corporation agreed to acquire Cardiva Medical, Inc., a privately-held maker of vascular closure systems based in Santa Clara, California, for $475 million upfront and up to $35 million in contingent consideration. The acquisition expands Haemonetics' hospital portfolio and its presence in the interventional cardiology and electrophysiology markets and is expected to be accretive to revenue growth.

Hellman & Friedman and Bain Capital Acquire athenahealth for $17 Billion

February 15, 2022

Cloud & SaaS

Affiliates of Hellman & Friedman and Bain Capital completed the $17 billion acquisition of athenahealth from Veritas Capital and Evergreen Coast Capital. The deal brings in additional coinvestors (including an affiliate of GIC and a subsidiary of ADIA) while Veritas and Evergreen each retain minority investments as the buyers look to scale athenahealth's cloud-based healthcare SaaS platform.

ARES (Highlander Partners Portfolio Company) Acquires Cardiomed Cluj

December 22, 2021

Healthcare Services

ARES, a leading Romanian interventional cardiology operator controlled by Highlander Partners, has acquired Cardiomed Cluj to create an integrated cardiology platform in Cluj-Napoca. The deal brings Cardiomed’s large outpatient and imaging capabilities into the ARES network to expand early diagnosis, imaging and interventional cardiology services; Cardiomed founder Dr. Carmen Mureșan will continue to lead the business.

Cardinal Health Acquires Specialty Networks from Linden Capital for $1.2B

January 31, 2024

Healthcare Services

Cardinal Health has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization, from Linden Capital Partners for $1.2 billion in cash. The deal adds Specialty Networks' GPOs, PPS Analytics platform and life-sciences/research capabilities to Cardinal Health's Specialty business to accelerate capability expansion across urology, gastroenterology and rheumatology.

ARCHIMED Acquires Majority Stake in Cardioline

November 17, 2021

Medical Devices

Trans-Atlantic private equity firm ARCHIMED has acquired a majority stake in Cardioline, a Trento, Italy-based maker of cardiology devices and Europe's largest provider of cardiology-focused telemedicine. The investment, made through ARCHIMED's MED III Fund, will support Cardioline's product and software development, international expansion and potential add-on M&A while founders retain a significant minority stake and remain in management.